Baron Silver Stevens Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Baron Silver Stevens Financial Advisors's PFE Position: Q2 2026 in Review
Baron Silver Stevens Financial Advisors reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $7.85K and leaving 22,560 shares worth $543K. The position accounts for 0.07% of the portfolio, ranked #89.
Baron Silver Stevens Financial Advisors first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $876K in Q2 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Baron Silver Stevens Financial Advisors held 22,560 shares of Pfizer worth $543K as of Q2 2026.
- Baron Silver Stevens Financial Advisors sold 300 Pfizer shares in Q2 2026, an estimated $7.85K.
- Pfizer made up 0.07% of Baron Silver Stevens Financial Advisors's portfolio in Q2 2026, its #89 holding.
- Baron Silver Stevens Financial Advisors first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
- Baron Silver Stevens Financial Advisors's Pfizer position peaked at $876K in Q2 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Baron Silver Stevens Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.